PDF herunterladen
CC BY-NC-ND 4.0 · Ann Natl Acad Med Sci 2022; 58(02): 078-086
DOI: 10.1055/s-0042-1743133
Original Article

Protective Effect of Nelumbo nucifera Plant on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Rats

Jignesh I. Patel
1   Department of Pharmacology, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
,
Monika Kumbhani
1   Department of Pharmacology, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
,
Morvi M. Raval
1   Department of Pharmacology, B. K. Mody Government Pharmacy College, Rajkot, Gujarat, India
› Institutsangaben
› Weitere Informationen
   Lizenzen und Reprints

Abstract

Objectives Ulcerative colitis is a global disease with increasing incidence and worldwide prevalence. So this study was undertaken to observe antiulcerative colitis activity of ethanolic extract of seeds of Nelumbo nucifera plant on dextran sodium sulfate (DSS)-induced ulcerative colitis in rats.

Materials and Methods The effect of ethanolic extract of N. nucifera seed (EENNS) was studied on DSS-induced ulcerative colitis in albino Wistar rats for 11 days. Disease pathogenesis was assessed by evaluation of disease activity index (DAI) including the following parameters: change in body weight, stool constituency, rectal bleeding in animals. Estimation of myeloperoxide (MPO), nitric oxide (NO), and antioxidant parameters like malondialdehyde (MDA), superoxide dismutase (SOD), and catalase level was performed in colon homogenate of animals. TNF-α (tumor necrosis factor- α) level was measured in colon homogenate using rat TNF-α ELISA kit.

Statistical Analysis Significant differences (mean ± standard error of the mean) were detected using one-way analysis of variance followed by post-test using Graphpad prism 7.0 for multiple comparisons.

Results EENNS (400 mg/kg) significantly improved the disease progression, body weight, and colon length of the animals as compared with the disease control group. Animal treated with EENNS (400 mg/kg) showed significantly improved colon mucosal damage index (1.66 ± 0.21) and DAI (11.66 ± 4.01) as compared with the disease control group. A higher level of SOD and catalase and a lower level of MDA were observed in animals treated with EENNS (400 mg/kg) as compared with the disease control group. Animals treated with EENNS (400 mg/kg) significantly decreased in NO and MPO levels as compared with the disease control group. A lower level of TNF-α (561.94 ± 14.84) was observed in EENNS (400 mg/kg)-treated animals as compared with the disease control group (736.92 ± 15.3). These observations were comparable to those of the standard control group. Histopathological data showed that EENNS (400 mg/kg) has shown reversal of tissue inflammation as compared with the disease group and evidence of less cell infiltration of lymphocytes and monocytes with normal structures of goblet cell and crypts as compared with the disease group.

Conclusion EENS (400 mg/kg) can decrease the severity of the UC produced by DSS. EENNS showed a protective effect against DSS-induced ulcerative colitis which may be due to its antioxidant and anti-inflammatory activity.

Keywords

ulcerative colitis - DSS - Nelumbo nucifera


Publikationsverlauf

Artikel online veröffentlicht:
07. März 2022

© 2022. National Academy of Medical Sciences (India). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Kim DH, Cheon JH. Pathogenesis of inflammatory bowel disease and recent advances in biologic therapies. Immune Netw 2017; 17 (01) 25-40
    CrossrefPubMedGoogle Scholar
  • 2 Su HJ, Chiu YT, Chiu CT. et al. Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates. J Formos Med Assoc 2019; 118 (07) 1083-1092
    CrossrefPubMedGoogle Scholar
  • 3 Ray G. Inflammatory bowel disease in India - past, present and future. World J Gastroenterol 2016; 22 (36) 8123-8136
    CrossrefPubMedGoogle Scholar
  • 4 Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res 2018; 16 (01) 26-42
    CrossrefPubMedGoogle Scholar
  • 5 Ke F, Yadav PK, Ju LZ. Herbal medicine in the treatment of ulcerative colitis. Saudi J Gastroenterol 2012; 18 (01) 3-10
    CrossrefPubMedGoogle Scholar
  • 6 Bhardwaj A, Modi KP. A review on therapeutic potential of Nelumbo nucifera (Gaertn): the sacred lotus. Int J Pharm Sci Res 2016; 7 (01) 42-54
    Google Scholar
  • 7 Zhao L, Wang X, Chang Q. et al. Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol 2010; 627 (1–3): 304-312
    CrossrefPubMedGoogle Scholar
  • 8 Xiao JH, Zhang JH, Chen HL, Feng XL, Wang JL. Inhibitory effects of isoliensinine on bleomycin-induced pulmonary fibrosis in mice. Planta Med 2005; 71 (03) 225-230
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Kwon KH, Murakami A, Tanaka T, Ohigashi H. Dietary rutin, but not its aglycone quercetin, ameliorates dextran sulfate sodium-induced experimental colitis in mice: attenuation of pro-inflammatory gene expression. Biochem Pharmacol 2005; 69 (03) 395-406
    CrossrefPubMedGoogle Scholar
  • 10 Wethangkaboworn Y, Munglue P. Effect of ethanolic seed extract of Nelumbo nucifera on male rat sexual behavior. KKU Res J 2014; ;19(Supplement Issue): 156-161
    Google Scholar
  • 11 Kokate CK, Gokhle SB, Purohit AP. Pharmacognosy. Pune: Nirali Prakashan; 2009
    Google Scholar
  • 12 Chen Y, Fan G, Wu H, Wu Y, Mitchell A. Separation, identification and rapid determination of liensine, isoliensinine and neferine from embryo of the seed of Nelumbo nucifera Gaertn. by liquid chromatography coupled to diode array detector and tandem mass spectrometry. J Pharm Biomed Anal 2007; 43 (01) 99-104
    CrossrefPubMedGoogle Scholar
  • 13 Paranthaman R, Praveen Kumar P, Kumaravel S. GC-MS analysis of phytochemicals and simultaneous determination of flavonoids in Amaranthus caudatus (Sirukeerai) by RP-HPLC. J Anal Bioanal Tech 2012; 3 (05) 1-4
    Google Scholar
  • 14 Vikrama Chakravarthi P, Gopakumar N, Nair AMC, Joy AD. Anti-inflammatory activity of Red and White Lotus seeds (Nelumbo nucifera) in Albino Rats. Vet World 2010; 3 (04) 157-159
    CrossrefGoogle Scholar
  • 15 Patel SH, Rachchh MA, Jadav PD. Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease. Indian J Pharmacol 2012; 44 (06) 744-748
    CrossrefPubMedGoogle Scholar
  • 16 Chaudhary G, Mahajan UB, Goyal SN, Ojha S, Patil CR, Subramanya SB. Protective effect of Lagerstroemia speciosa against dextran sulfate sodium induced ulcerative colitis in C57BL/6 mice. Am J Transl Res 2017; 9 (04) 1792-1800
    PubMedGoogle Scholar
  • 17 Koppikar SJ, Jagtap SD, Devarshi PP. et al. Triphala, an Ayurvedic formulation improves the antioxidant status on TNBS induced IBD in rats. Eur J Integr Med 2014; 6 (06) 646-656
    CrossrefGoogle Scholar
  • 18 Camacho-Barquero L, Villegas I, Sánchez-Calvo JM. et al. Curcumin, a Curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol 2007; 7 (03) 333-342
    CrossrefPubMedGoogle Scholar
  • 19 Pandurangan AK, Mohebali N, Norhaizan ME, Looi CY. Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug Des Devel Ther 2015; 9: 3923-3934
    CrossrefPubMedGoogle Scholar
  • 20 Lin JY, Lai YS, Liu CJ, Wu AR. Effects of lotus plumule supplementation before and following systemic administration of lipopolysaccharide on the splenocyte responses of BALB/c mice. Food Chem Toxicol 2007; 45 (03) 486-493
    CrossrefPubMedGoogle Scholar
  • 21 Randhawa PK, Singh K, Singh N, Jaggi AS. A review on chemical-induced inflammatory bowel disease models in rodents. Korean J Physiol Pharmacol 2014; 18 (04) 279-288
    CrossrefPubMedGoogle Scholar